ISA Pharmaceuticals Appoints Hendrik-Jan Laseur as Member of the Supervisory Board

03 Sep 2014

Leiden, The Netherlands, September 3, 2014 – ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company focusing on rationally designed immunotherapeutics against cancer and persistent viral infections, today announced the appointment of Hendrik-Jan Laseur to its Supervisory Board.

Hendrik-Jan Laseur has an outstanding track record in advising foundations, non-governmental organizations and financial institutions. Among others, he currently serves as a Board member of the Center for Public Integrity (Washington, DC, USA), as a member of the Advisory Board of SustainAbility (London, UK) and as a Board member of the Adessium Foundation (Rotterdam, The Netherlands).

Hendrik-Jan Laseur is the founder of Laseur – Lead the

Read more »